Cartilage Repair Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook
Date : November 2024
Cartilage Repair Market Size Analysis and Top Companies
The global cartilage repair market size is estimated to hit around USD 5.18 billion by 2033 from USD 1.85 billion in 2024 with a CAGR of 12.13% from 2024 tpo 2033. The top companies operating in the cartilage repair market are Smith+ Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen AG, The Future of Biotechnology, MEDIPOST, Vericel Corporation, CONMED Corporation, Medical Devices Business Services, Meril Life Sciences Pvt. Ltd., Arthrex, Inc., Medacta International, Teijin Nakashima Medical Co., Ltd., BioTissue SA, ISTO Technologies, Inc., CartiHeal, Inc., Mathys AG Bettlach, Waldemar Link GmbH & Co.KG, JRI Orthopaedics, Regentis Biomaterials Ltd. and Others.
Market Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 1.85 Billion |
| Market Size by 2034 | USD 51.81 Billion |
| Growth Rate from 2024 to 2034 | CAGR of 12.13% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | By Type, By Application, By Treatment Type and By Site |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Cartilage Repair Market Companies
- Smith+ Nephew
- Stryker
- Zimmer Biomet
- B. Braun Melsungen AG
- The Future of Biotechnology
- MEDIPOST
- Vericel Corporation,
- CONMED Corporation
- Medical Devices Business Services (DePuy Synthes)
- Meril Life Sciences Pvt. Ltd.
- Arthrex, Inc.
- Medacta International
- Teijin Nakashima Medical Co., Ltd.
- BioTissue SA
- ISTO Technologies, Inc.
- CartiHeal, Inc.
- Mathys AG Bettlach
- Waldemar Link GmbH & Co.KG
- JRI Orthopaedics
- Regentis Biomaterials Ltd.
- Auxein Medical.
- EVOLUTIS INDIA PVT. LTD.
- Japan MDM, Inc.
Recent Developments
- In April 2020, Eisai Co., Ltd. and Seikagaku Corporation signed a co-development and commercialization agreement for SI-613, a therapeutic agent for the treatment of osteoarthritis. Diclofenac conjugated sodium hyaluronate makes up SI-613. Companies would jointly develop SI-613 in China in accordance with the agreement.
- In April 2018, Stryker and AlloSource announced the availability of ProChondrixCR, a cryopreserved osteochondral allograft. It aims to provide patients in need of articular cartilage restoration with better solutions.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
Keypoints
- Company Overview
- Locations & Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Corporate Strategy
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking